Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 192.97

-1.6%

Jan 16 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: bob zagorin who wrote (3262)	6/3/1997 12:58:00 AM
From: PSC	of 32384

From a science perspective: Flt-3 is a blood cell and dendritic cell receptor, not at all analagous to the retinoic acid receptors that Ligand concentrates on, but rather a tyrosine kinase receptor. Unless Ligand is focussing on other receptor ligands as well, this is no competition. Plus, as we learn more about cancer genesis (carcinogenesis), we find that there are multiple etiologies, all of which may benefit from specific therapies that address that specific target. To me that translates into plenty of room for lots of biotech products in the future to treat cancer, since there are so many forms and causes and pathophysiologies. Do you agree Henry?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next